Company: HURA
Filing Date: 2025-08-12
Form Type: S-1
Source: 0001193125-25-179009
Chunk: 120

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-08-12
Form: S-1
Chunk 120
---
 |     2023-553657 |     | 8/31/2023   |     |            |     |            |     | Pending |
| KR      |     | 10-2023-7033611 |     | 9/27/2023   |     |            |     |            |     | Pending |
| US      |     |       18/548729 |     | 9/1/2023    |     |            |     |            |     | Pending |

Patents Under License Agreements with H. Lee Moffitt Cancer Center PCT/US2017/030962 (filed 5/4/2017) – “A Delta-Opioid Receptor Targeted Agent for Molecular Imaging and Immunotherapy of Cancer” Applicants: University of South Florida and the H. Lee Moffitt Cancer Center Summary: Relates to compounds comprising at least one delta-opioid receptor ligand, such as Dmt-Tic, conjugated to an anti-PDl checkpoint inhibitor antibody and Dmt-Tic-antibodyconjugates and methods of use thereof to treat cancer. Earliest Expected Expiration Date: 5/4/2037

| Country |     | App. No.  |     | Filing Date |     | Grant Date |     | Patent No. |     | Status   |
| US      |     | 16/098906 |     | 11/5/2018   |     | 10/1/2019  |     |   10426843 |     | Granted  |
| US      |     | 16/587720 |     | 9/30/2019   |     |            |     |            |     | Inactive |
| US      |     | 17/830781 |     | 6/2/2022    |     | 1/7/2025   |     |   12186404 |     | Granted  |
| US      |     | 19/011258 |     | 1/6/2025    |     |            |     |            |     | Pending  |

PCT/US2015/038057 (filed 6/26/2015) – “Conjugates for Immunotherapy” Applicants: University of South Florida and the H. Lee Moffitt Cancer Center Summary: Relates to molecular conjugates comprising agonists of cell surface receptors specific to a target cell